These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37702239)

  • 1. DOCK4 is a Novel Prognostic Biomarker and Correlated with Immune Infiltrates in Colon Adenocarcinoma.
    Xie X; Lu Y; Wang B; Yin X; Chen J
    Comb Chem High Throughput Screen; 2024; 27(8):1119-1130. PubMed ID: 37702239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma.
    Zhu D; Feng H; Zhang Z; Li J; Li Y; Hou T
    Cancer Med; 2024 Aug; 13(15):e70043. PubMed ID: 39087856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
    Lu Y; Yu J; Dong Q; Du Y; Liang Z
    Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
    Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
    Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
    Meng C; Zhang Y; Jiang D; Wang J
    World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma.
    Chen X; Yi G; Zhou Y; Hu W; Xi L; Han W; Wang F
    Mediators Inflamm; 2023; 2023():4926474. PubMed ID: 37124063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
    Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
    Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
    Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
    World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma.
    Yang D; Cheng W; Liu Y; Ma L; Sun Y; Wang H; Liu H; Nan L; Yang Y; Wang X
    Int J Immunopathol Pharmacol; 2024; 38():3946320241286565. PubMed ID: 39423024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
    Wang Z; Niu D
    Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis poor, immune infiltration of colon adenocarcinoma associated with low expression levels of calcium-activated chloride channel.
    Zhao X; Chen Y; Wang L; Sui D; Lu J
    Pol J Pathol; 2024; 75(2):138-152. PubMed ID: 39166522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
    Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
    Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
    Westbrook JA; Wood SL; Cairns DA; McMahon K; Gahlaut R; Thygesen H; Shires M; Roberts S; Marshall H; Oliva MR; Dunning MJ; Hanby AM; Selby PJ; Speirs V; Mavria G; Coleman RE; Brown JE
    J Pathol; 2019 Mar; 247(3):381-391. PubMed ID: 30426503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics.
    Xiao Y; Peng Y; Wan J; Tang G; Chen Y; Tang J; Ye WC; Ip NY; Shi L
    J Biol Chem; 2013 Jul; 288(27):20034-45. PubMed ID: 23720743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma.
    Zhao P; Ning J; Huang J; Wei B; Wang Z; Huang X
    Int J Gen Med; 2023; 16():4595-4615. PubMed ID: 37850194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.